Bovie Medical (BVX) News Today → The #1 Opportunity of the decade? (From Behind the Markets) (Ad) Free BVX Stock Alerts $6.48 +0.07 (+1.09%) (As of 12/31/2018) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadline2023-2030 Medical Smoke Evacuation System Market Size with [113 Pages] includes Recent Developments | New Report by Absolute Reportsmarketwatch.com - April 21 at 11:38 PMBovie Medical earnings: here's what Wall Street expectsmarkets.businessinsider.com - March 17 at 7:50 PMElectrosurgical Devices Global Market Report 2022: Featuring Olympus, Bovie Medical, ATMOS, Johnson and Johnson & Morefinance.yahoo.com - January 22 at 1:27 PMBovie Medical Corporation (BVX): Today's Featured Health Care Loserthestreet.com - January 11 at 6:34 PMMEDICAL MYSTERIESwashingtonpost.com - October 16 at 7:47 PMBovie Medical (BVX) Looks Good: Stock Moves 9.1% Higherfinance.yahoo.com - October 26 at 3:45 PM Get Bovie Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for BVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Tiny Biotech Stock Wins $75 Billion Patent (Ad)A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda. Find out more here >>> BVX Media Mentions By Week BVX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BVX News Sentiment▼0.000.52▲Average Medical News Sentiment BVX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BVX Articles This Week▼00▲BVX Articles Average Week Get Bovie Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for BVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Pro-Dex News Acrivon Therapeutics News Compass Therapeutics News Elevation Oncology News Lineage Cell Therapeutics News Stereotaxis News Merrimack Pharmaceuticals News G1 Therapeutics News Innate Pharma News Abeona Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:BVX) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchThe #1 Crypto for 2024InvestorPlaceYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bovie Medical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.